427 Plasma and urinary pharmacokinetics of the novel, oral SHIP1 activator, AQX-1125 in interstitial cystitis/bladder pain syndrome (IC/BPS): Results of the phase2 LEADERSHIP trial

2016 ◽  
Vol 15 (3) ◽  
pp. e427
Author(s):  
C. Nickel ◽  
R. Evans ◽  
P. Tam ◽  
J. Toews ◽  
L. MacKenzie ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document